Carmell Co. (NASDAQ:CTCX) Sees Significant Growth in Short Interest

Carmell Co. (NASDAQ:CTCXGet Free Report) was the target of a significant growth in short interest in the month of May. As of May 31st, there was short interest totalling 35,500 shares, a growth of 18.3% from the May 15th total of 30,000 shares. Approximately 0.3% of the company’s stock are short sold. Based on an average daily trading volume, of 10,700 shares, the short-interest ratio is presently 3.3 days.

Carmell Trading Down 8.0 %

CTCX stock opened at $1.83 on Tuesday. The firm has a 50 day moving average price of $2.29 and a 200-day moving average price of $2.91. Carmell has a 52-week low of $1.70 and a 52-week high of $13.31.

Carmell (NASDAQ:CTCXGet Free Report) last released its earnings results on Wednesday, May 15th. The company reported ($0.16) earnings per share (EPS) for the quarter.

Hedge Funds Weigh In On Carmell

A number of hedge funds have recently added to or reduced their stakes in the company. Meteora Capital LLC bought a new stake in Carmell in the 3rd quarter worth approximately $6,416,000. Linden Advisors LP bought a new stake in shares of Carmell during the 3rd quarter valued at $270,000. Finally, Hubbell Strickland Wealth Management LLC bought a new stake in shares of Carmell during the 1st quarter valued at $32,000. 24.22% of the stock is currently owned by hedge funds and other institutional investors.

Carmell Company Profile

(Get Free Report)

Carmell Corporation operates as a bio-aesthetics company. The company utilizes Carmell Secretome to support skin and hair health. Its Carmell Secretome consists of growth factors and proteins extracted from allogeneic human platelets sourced from tissue banks. The company also developed a microemulsion formulation that enables delivery of lipophilic and hydrophilic ingredients without relying on the Foul Fourteen, 14 potentially harmful excipients that are commonly used by other companies to impart texture, stability, and other desirable physicochemical attributes to cosmetic products.

Further Reading

Receive News & Ratings for Carmell Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carmell and related companies with's FREE daily email newsletter.